PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17175307-17	2006	We concluded that patients with early CAN who are switched to SRL and low-dose CsA have a significant attenuation of the rate of GFR declination when compared with patients who receive MMF or AZA addition.	Sirolimus	62-65	Rap guanine nucleotide exchange factor 5	Homo sapiens	129-132	
25307036-10	2014	These findings suggest that sirolimus is more effective in improving GFR in patients without preexisting diabetes, and adequate MMF doses are needed for sirolimus conversion.	Sirolimus	28-37	Rap guanine nucleotide exchange factor 5	Homo sapiens	69-72